Vivos Therapeutics, Inc. Common Stock (VVOS)
Since May 17, 2021, Vivos Therapeutics, Inc. Common Stock (VVOS) has reported earnings 17 times. On average the shares move ±10.91% post-earnings, with a positive reaction 35.3% of the time. Its largest post-earnings gain was +18.13% (Aug 12, 2021) and its largest decline was -23.65% (Apr 15, 2026). The next earnings report is predicted for 2026-11-16 (high confidence).
Earnings reactions
How VVOS moved on each past earnings report.
Earnings Impact
Total Earnings
17
Avg Abs. Movement
±10.91%
Positive %
35.3%
Negative %
64.7%
Historical Earnings Statistics
| Date | Timing | Earnings move | SEC Filing |
|---|---|---|---|
| Apr 15, 2026 | ☽ POST | -23.65% | open_in_new |
| Nov 19, 2025 | ☽ POST | -7.63% | open_in_new |
| Aug 20, 2025 | ☽ POST | +3.37% | open_in_new |
| May 15, 2025 | ☽ POST | -19.07% | open_in_new |
Earnings Count
17
Total earnings in dataset
Avg Abs. Movement
±10.91%
Avg % price change on earnings
Institutional ownership
Holdings as of Jun 30, 2026 · SEC 13-F
SEC Filing Types
Recent SEC Filings
10 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K/A | 20260908 | open_in_new SEC.gov |
| 8-K | 20260908 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260903 | open_in_new SEC.gov |
| 4 | 20260826 | open_in_new SEC.gov |
| 8-K | 20260821 | open_in_new SEC.gov |
| 10-Q | 20260814 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260814 | open_in_new SEC.gov |
| 8-K | 20260811 | open_in_new SEC.gov |
| SCHEDULE 13G | 20260811 | open_in_new SEC.gov |
| 8-K | 20260803 | open_in_new SEC.gov |
Frequently asked about VVOS earnings
When does Vivos Therapeutics, Inc. Common Stock report earnings next? expand_more
Vivos Therapeutics, Inc. Common Stock (VVOS)'s next earnings date is predicted (high confidence) for 2026-11-16. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does VVOS stock move after earnings? expand_more
Over 17 reports, VVOS has moved an average of ±10.91% the session after earnings, closing higher 35.3% of the time.
What was VVOS's biggest post-earnings move? expand_more
VVOS's largest post-earnings gain on record was +18.13% on Aug 12, 2021, and its largest decline was -23.65% on Apr 15, 2026.
Where can I find Vivos Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Vivos Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right